The “de-regulator” hypothesis might also explain the association of CFHR3/CFHR1 deficiency with a decreased risk for AMD, as a lack of FHR-3 would thus allow for better surface binding and consequently complement regulation by FH [17]. The gene discussed is CFHR3; the disease is age-related macular degeneration.